January 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreJuly 24, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJuly 24, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreApril 21, 2026
Projections indicate that, Latin America Behavioral Health industry is projected to rise from USD 5.2 billion in 2024 to USD 9.98 billion by 2034, reflecting a CAGR of 6.74% over the next decade. The market is growing due to rising mental health awareness and digital therapy adoption. In Latin America, growth is driven by expanding healthcare acces...
April 21, 2026
Based on market forecasts, the APAC behavioral health sector will expand from USD 19.07 billion in 2024 to USD 56.58 billion by 2034, experiencing a CAGR of 11.49%. The rising prevalence of mental health disorders and technological advancements drive the market....
April 21, 2026
Projections indicate that, the APAC biotechnology market will increase from USD 372.23 billion in 2024 to USD 1611.67 billion by 2034, experiencing a CAGR of 14.80% over the next 10 years. The APAC biotechnology market is growing due to rising government initiatives in the region....
April 21, 2026
Based on market forecasts, the Europe life science market, projected at USD 26.32 billion in 2024, is expected to reach USD 78.90 billion by 2034, growing at a CAGR of 11.61% over the forecast period. The growing public health concerns, significant scientific advancements, industrial competitiveness, and sustainability initiatives supported the rob...
April 21, 2026
Based on market forecasts, the APAC life science market, projected at USD 17.51 billion in 2024, is expected to reach USD 54.81 billion by 2034, growing at a CAGR of 12.09% over the forecast period. The market is growing due to the rising demand for advanced tools and biopharmaceutical innovations. The Asia Pacific region is dominating with rising ...
April 21, 2026
According to market projections, the U.S. healthcare revenue cycle management sector is expected to grow from USD 65.38 billion in 2025 to USD 195.92 billion by 2035, reflecting a CAGR of 11.6%. The U.S. healthcare revenue cycle management market is growing due to rising healthcare investments and chronic conditions....
April 21, 2026
Projections indicate that, Middle East & Africa behavioral health industry is projected to rise from USD 5.2 billion in 2024 to USD 9.99 billion by 2034, reflecting a CAGR of 6.75% over the next decade. The rising prevalence of mental health disorders and technological advancements drive the market. GCC countries dominated due to the increasing...
April 21, 2026
Projections indicate that, Middle East and Africa life science industry is projected to rise from USD 4.47 billion in 2024 to USD 13.07 billion by 2034, reflecting a CAGR of 11.32% over the next decade. The market is expanding due to rising R&D investments, technological advancements, and growing demand for precision medicine. In the Middle Eas...
April 21, 2026
Projections indicate that, the global Latin America life science market will increase from USD 4.49 billion in 2024 to USD 12.05 billion by 2034, experiencing a CAGR of 10.38% over the next 10 years. The market is expanding rapidly due to rising R&D investments, technological advancements, and growing demand for precision medicine and diagnosti...
April 21, 2026
According to market projections, the respiratory health supplements sector is expected to grow from USD 8.78 billion in 2025 to USD 18.52 billion by 2035, reflecting a CAGR of 7.75%. The respiratory health supplements market is growing due to rising pollution leading to respiratory disorders. Asia Pacific dominated the market due to a large geriatr...